Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Sleep Wake Disorders 1Radiation Injuries 1Pinealoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Meningioma 1Medulloblastoma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Fatigue 1Ependymoma 1Depression 1Craniopharyngioma 1Cognition Disorders 1Chronic Pain 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1Anxiety Disorders 1

Interventions

Psilocybin 6Therapeutics 2Ketamine 2Exercise 2Venlafaxine Hydrochloride 1Vegetables 1Terminal Care 1Self-Management 1SLI381 1Psychotherapy 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Professional Autonomy 1Niacin 1Mirtazapine 1Minocycline 1Methylphenidate 1Mental Status and Dementia Tests 1Melatonin 1Medical Marijuana 1Interpersonal Psychotherapy 1Injections 1Infliximab 1Gemcitabine 1Fruit 1Fluoxetine 1Ethanol 1Doxorubicin 1Donepezil 1Dignity Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Depression × Donepezil × Clear all
NCT01466270 2021-10-20

Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

Wake Forest University Health Sciences

Phase 2 Completed
62 enrolled 12 charts
Breast

Anxiety Disorders, Breast Neoplasms, Cognition Disorders, Depression, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡